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Abstract 
Objectives: To investigate the main characteristics and the precision of outcomes 
between updated and original systematic reviews (SRs). 
Study Design and Setting: We searched PubMed and Embase.com on 31 March 
2019, and included 30 pairs of updated and original SRs. We calculated changes in 
outcomes and the precision of effect size estimates in updated SRs, compared with 
original SRs. Review Manager 5.3 software was adopted to create forest plots 
showing comparable outcomes. 
Results: The average update time was 56.0 months, and incorporating new trials (23 
SRs, 76.7%) was the main reason for the update. Compared with original SRs, 24 
(80.0%) updated SRs included more randomized controlled trials (RCTs) and 22 
(73.3%) updated SRs involved a larger number of patients. Of the 130 comparable 
outcomes, only three (2.3%) outcomes were observed with a significant change in 
three SR updates. No new data from RCTs were added to 36 (27.7%) outcomes during 
the update process. Of the 94 outcomes including new evidence, 83 (88.3%) showed 
an improvement in precision, 5 (5.3%) showed a decrease, and 6 (6.4%) did not 
exhibit changes in precision. 
Conclusion: Updating SRs could increase the precision of most c mparable outcomes, 
although the conclusions of almost all updated SRs were similar to original SRs. 
  
Keywords: Meta-analysis; Update; Treatment effect, Evidence certainty, Outcome 
change; Meta-epidemiology 
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What is new? 
 
Key findings 
 Systematic reviews did not exhibit outcome changes during the update process. 
 Updating systematic reviews could increase the precision of estimates of 
treatment effects. 
 Most updated systematic reviews only briefly describe the reasons for updating 
and some cannot be identified as updated SRs. 
What this adds to what was known? 
 This study compared the general characteristics, statistical methods, and the 
precision of outcomes between updated SRs and original SRs. 
What is the implication and what should change now? 
 Researchers, journal editors, and peer reviewers should fully assess the need for 
updates and encourage authors to clarify the detailed reasons for the updates.  
 Future research should fully consider multiple factors when updating systematic 
reviews to ensure that the results of systematic reviews better guide the clinical 
practice and avoid wasting resources and time. 
 
1. Introduction 
 
Systematic reviews (SRs) are fundamental scientific activities [1, 2], and help 
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clinicians keep up with the pace of medical literatu e by summarizing a large amount 
of evidence and explaining the differences in results between studies [3]. It was 
estimated that more than 8,000 SRs were indexed in Medline annually, which is 
equivalent to a threefold increase over the past decade [4, 5]. SRs are increasingly 
used in medical decision-making, pointing out the direction of future research, 
formulating clinical policies, and combining the best vidence with clinical practice [6, 
7]. However, if the SR report is incomplete or the implementation method is flawed, 
the role of the SR in decision-making will be limited [8]. When health care workers 
apply the results of SRs in practice, they should first assess the validity of the SRs [9]. 
However, there is abundant evidence showed that the results of SRs may be outdated 
with the progress of research, and an SR is most useful when it is kept up to date 
[10-12]. 
The panel for updating guidance for the SRs group defines an update of SRs as a 
new version of the published SRs [10]. Updating SRs can include newly published 
studies and some gray literature, which can reduce p blication bias and improve the 
credibility of the results of SRs [11-13]. Because systematic reviews are relatively 
more influential in evidence-based clinical decision-making compared to other study 
designs, it has been suggested that regularly updating of systematic reviews is needed 
to ensure that the evidentiary basis is current, complete, and as precise as possible 
[14-16]. Updated SRs may generate new and very important information, but the 
process of updating the SR is time-consuming and laborious, and may also inflate 
type I errors [10, 17, 18]. Previous studies have summarized methods and strategies 
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regarding when and how to update SRs [19], identifid the signals for the need to 
update SRs [20], tested the effectiveness of simplified search strategies for updating 
SRs [21], and determined characteristics that needed to stimate the risk of conclusion 
changes in SR updates [22]. However, there was a lack of empirical evidence on 
differences in characteristics and outcome changes between updated and original SRs. 
The primary objective of this study was to investiga e the general characteristics 
of included SRs and compare these factors between updated SRs and original SRs of 
health care interventions. The secondary objective was to examine whether the 
updated SRs exhibited outcomes change and whether updated SRs improved the 
precision of outcomes. We did not attempt to explore the differences of 
methodological and reporting quality between update SRs and original SRs, as these 
were already reported in our previous study [23]. 
 
2. Methods 
 
2.1. Search strategy 
 
We conducted comprehensive electronic searches in PubMed and Embase.com to 
identify updated SRs from inception to March 3, 2019. Search terms included the 
following words: “systematic review”, “meta-analysis”, “indirect comparison”, 
“indirect treatment”, “mixed treatment comparison”, “multiple treatment comparison”, 
and “update”. A combination of subject terms and keywords was used and we made 
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appropriate adjustments of vocabulary and grammar between different databases. We 
applied no restriction on publication date. The search strategies are presented in 
Appendix Word 1. Reference lists of relevant SRs were manually search d for 
potentially eligible studies. 
 
2.2. Inclusion and exclusion criteria 
 
Eligibility criteria are the same as those reported in our previous research [23]. 
Systematic reviews of interventions with or without meta-analysis that met the 
following criteria were included: (1) was a review article and explicitly described 
methods of study selection, and explicitly reported the methods of evidence synthesis 
[5, 24]; (2) all the original SRs and updated SRs included only randomized controlled 
trials (RCTs) or quasi-randomized controlled trials to evaluate clinical effects of 
health care interventions (including pharmaceutical agents, surgeries, and health 
technologies); and (3) all the original SRs and update  SRs were published in the 
English language. 
We excluded following studies: (1) SRs that included both RCTs and 
nonrandomized studies or only included nonrandomized studies; (2) SRs did not focus 
on health care interventions such as etiology, diagnosis, and prognosis; (3) SRs did 
not clearly state "update" in the titles or articles; (4) the original SR or updated SR is a 
Cochrane review; (5) the second analysis of previous SR; (6) overviews of SRs, 
methodological reviews, umbrella overviews, scoping or rapid reviews, review 
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protocols, abstracts, conference proceedings, and letters to editors. 
 
2.3. Study selection 
 
The retrieved records were imported into EndNote X8 (Thomson Reuters 
(Scientific) LLC Philadelphia, PA, US) for management. The titles and abstracts of 
the identified records from the electronic database search were screened by two 
independent reviewers (Y.G. and Y.T.C.) to determine if they met the inclusion criteria. 
Then, the same two reviewers retrieved the full text of all possibly relevant studies 
and assessed the eligibility of each study according to the inclusion criteria. If we 
identified SRs with more than one updated version, the most recent one was included. 
Conflicts were resolved through discussions with a ird reviewer (J.H.T.). 
 
2.4. Data extraction 
 
We developed a data extraction form using Microsoft Excel 2016 (Microsoft 
Corp, Redmond, WA, www.microsoft.com) through discussions with the review team 
and revised it after piloting on a random of five SRs. Then, one reviewer (Y.G., 
K.L.Y., Y.T.C., or S.Z.S) extracted data from the included SRs and a second reviewer 
(J.H.T.) checked the extracted data. The detailed data included: (1) general 
information: first author, year of publication, country of the corresponding author, 
number of authors, journal name, subject, details of inclusion criteria, number of 
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included studies, and number of participants; (2) quality of RCTs included in updated 
SRs and original SRs: random sequence generation, all cation concealment, blinding 
of participants and personnel, and blinding of outcme assessment; (3) main results: 
summary measures, effect size, 95% confidence intervals (95% CIs), and P value. 
Disagreements were resolved by consensus or by the discussion with a third reviewer 
(J.H.T.). 
 
2.5. Data management and analysis 
 
We compared the general characteristics between updated SRs and original SRs. 
Frequency and percentage were used for categorical variables, and median and 
interquartile range were used for continuous variables. We used the Chi-squared test 
or Fisher exact test (if a contingency table contained a cell with five or fewer events) 
to assess the differences in categorical data and no parametric statistical approach 
(two-sample Wilcoxon rank-sum test) or Student t-tes  for continuous data [5, 24]. 
The analyses were conducted using IBM SPSS Statistics v. 24.0 (Armonk, NY: IBM 
Corp). 
To determine whether updates exhibited an outcome change, we extracted 
comparative outcomes from the updated SRs and original SRs. Outcomes were 
considered comparable when the updated SR and the original SR evaluated the same 
interventions and outcome indicators. Then, we calcul ted the ratio of effect size, the 
difference of standardized mean differences, and the difference of mean differences to 
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determine whether there was a change in outcome using the extracted data of 
comparative outcomes. Analyses were conducted by using STATA (13.0; Stata 
Corporation, College Station, Texas, USA Stata). We also used Review Manager 5.3 
software (Cochrane Collaboration, Oxford, UK) to create forest plots showing 
comparable outcomes to compare the precision of the results. 
 
3. Results 
 
3.1. Screening results 
 
The systematic search in PubMed, Embase.com, and reference lists yielded 4997 
records, with 2214 duplicates. After screening titles and abstracts of the remaining 
2783 records, 2536 were considered irrelevant and excluded. Further assessing the 
full-text and retrieving the relevant original SRs of the remaining 247 records, a total 
of 60 SRs was included for the analyses, including 30 updated SRs and 30 original 
SRs. The flowchart of the screening process is presented i  Appendix Figure 1. The 
full lists of included SRs can be found in Appendix Word 2. 
 
3.2. General characteristics of included SRs 
 
The included SRs were published between 1994 and 2018 with the majority of 
them (70.0%) published after 2007 (Figure 1). 60 SRs were conducted in 19 countries, 
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and the United Kindom ranked first, with 12 publicat ons (Appendix Figure 2). The 
included SRs covered a wide range of disease categories, 10 (16.7%) focused on 
neoplasms, 8 (13.3%) related to diseases of the circulatory system, and 6 (10.0%) 
focused on diseases of the musculoskeletal system and connective tissue and diseases 
of the digestive system, respectively (Figure 2). 
Table 1 summarized the characteristics of the included SRs. 20 original SRs and 
26 updated SRs published in journals with impact faors between 0.0 and 9.0, and 
there was no significant difference between the updated SRs and original SRs. 70.0% 
of the SRs completed by one to six authors. The median number of RCTs included in 
original SRs was 13.5, and the median number of samples was 1625. The updated 
SRs included a median of 18.5 RCTs involving a median number of 2419 patients, 
and significant differences were observed in the number of included RCTs and 
samples between the updated SRs and original SRs (Table 1). Only 36.7% of the 
original SRs conducted subgroup analyses, 40.0% performed sensitivity analyses, and 
no original SRs performed meta-regression analyses. As for updated SRs, 53.3% 
performed subgroup analyses, 33.3% conducted sensitivity analyses, and 6.7% 
conducted meta-regression analyses. The publication bias was evaluated in seven 
original SRs and six updated SRs, and significant publication bias was reported in two 
original SRs and three updated SRs. Of the 60 SRs, only two pairs of updated and 
original SRs used the Grading of Recommendations Assessment, Development and 
Evaluation (GRADE) [25] tool to assess the quality of evidence (Table 2). 
 
Table 1 The characteristics of the included SRs 
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Characteristics Original SRs (n=30) Updated SRs (n=30) P value 
Journal impact factor 
0.0 to 3.0 8(26.7) 11(36.7) 0.405 
3.1 to 6.0 8(26.7) 11(36.7) 0.405 
6.1 to 9.0 4(13.3) 4(13.3) 1.000 
> 9.0 9(30.0) 4(13.3) 0.117 
Non-SCI 1(3.3) 0(0.0) 1.000 
Number of authors 
1 to 3 authors 10(33.3) 8(26.7) 0.573 
4 to 6 authors 11(36.7) 13(43.3) 0.598 
7 or more authors 9(30.0) 9(30.0) 1.000 
Number of RCTs included: median (IQR) 13.5(7.75, 29.25) 18.5(9.75, 30) 0.010 
Number of patients included: median (IQR) 1625(662, 6800) 2419(955, 8898) 0.004 
SRs, systematic reviews; SCI, science citation index; RCTs, randomized controlled trials; IQR, interquartile range. 
 
Table 2 The statistical analyses of the included SRs 
Category Original SRs Updated SRs Frequency Proportion (%) 
Subgroup analysis conducted? Yes Yes 10 33.3 
No Yes 6 20.0 
Yes No 1 3.3 
No No 5 16.7 
 
Did not conduct meta-analyses No 2 6.7 
 
Did not conduct meta-analyses Did not conduct meta-analyses 6 20.0 
Sensitivity analysis conducted? Yes Yes 7 23.3 
 
No Yes 3 10.0 
 
Yes No 5 16.7 
No No 7 23.3 
Did not conduct meta-analyses  Yes 1 3.3 
Did not conduct meta-analyses No 1 3.3 
Did not conduct meta-analyses Did not conduct meta-analyses 6 20.0 
Meta-regression analysis conducted? Yes Yes 0 0.0 
No Yes 2 6.7 
Yes No 0 0.0 
No No 20 66.7 
Did not conduct meta-analyses No 2 6.7 
 
Did not conduct meta-analyses Did not conduct meta-analyses 6 20.0 
Publication bias assessed? Yes Yes 5 16.7 
No Yes 1 3.3 
Yes No 2 6.7 
No No 22 73.3 
GRADE used Yes Yes 2 6.7 
No Yes 1 3.3 
Yes No 0 0.0 
No No 27 90.0 
13 
SRs, systematic reviews; GRADE, Grading of Recommendations Assessment, Development and Evaluation. 
 
3.3. Reasons for updating and time interval of update 
 
The 30 original SRs were updated mainly for the following four reasons: to 
incorporate new trials (23 SRs, 76.7%), to assess whether new evidence will change 
the conclusion of the original SR (2 SRs, 6.7%), to assess detailed interventions (1 SR, 
3.3%), and original SR being criticized for its methodology and interpretation of 
results (1 SR, 3.3%). Twenty-five original SRs were updated once and five were 
updated two times. For SRs with one update, the median of the update interval was 
43.5 months. For SRs with two updates, the median update time was 51.0 months 
from the original SR to the first version of updated SR, and 79.0 months from the first 
version of updated SR to the latest updated SR. Overall, The average update time was 
56.0 months, Table 3. 
 
Table 3 Reasons for updating and time interval of update 
Category Frequency Proportion (%) 
Reasons for updating (n=30) 
Incorporate new trials 23 76.7 
Assess whether new evidence will change the conclusion of original SR 2 6.7 
Assess detailed interventions 1 3.3 
Original SR was criticized for its methodology and iterpretation of results 1 3.3 
Not reported 3 10.0 
Time interval of update (month) (n=30) 
SRs with 1 update (n=25) 
median (IQR) 43.5(27.25,68.75) 
Unclear 5 20.0 
SRs with 2 updates (n=5) 
Original SR to first updated SR: median (IQR) 51.0(39.5,71.0) 
First updated SR to latest updated SR: median (IQR) 79.0(36.5,110.5) 
Original SR to latest updated SR: median (IQR) 131.0(76. ,181.0) 
Overall: mean (IQR) (n=25) 56.0(34.0,79.5) 
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SRs, systematic reviews; IQR, interquartile range. 
 
3.4. Differences between updated SRs and original SRs 
 
Five (16.7%) updated SRs were published in a higher impact factor journal 
compared to original SRs, but half of the updated SRs were published in lower impact 
factor journals. Compared with original SRs, 14 (46.7%) updated SRs included more 
authors, 24 (80.0%) updated SRs included more RCTs, and 22 (73.3%) updated SRs 
involved a larger number of patients. As for changes in inclusion criteria, the most 
common aspect was the outcome (9, 75.0%), other factors included population (4, 
33.3%), intervention (6, 50.0%), and comparison (7, 58.3%). Appendix Table 1 
presents the details of the inclusion criteria. Considering literature search, 14 (46.7%) 
pairs searched the same number of databases, and 16 (53.3%) updated SRs searched 
the years that the original SRs covered. More than 80.0% updated SRs incorporated 
RCTs that previously included in the original SRs, and more than 60.0% updated SRs 
included no less than 90.0% of the previously included RCTs. The changed 
information between updated SRs and original SRs is summarized in Table 4. 
 
Table 4 Changed information between updated SRs and original SRs 
Category Frequency Proportion (%) 
Whether the impact factors change? 
Increase 5 16.7 
Reduce 15 50.0 
No change 10 33.3 
Whether the number of authors changes? 
Increase 14 46.7 
Reduce 7 23.3 
No change 9 30.0 
Whether the number of included RCTs changes? 
15 
Increase 24 80.0 
Reduce 4 13.3 
No change 2 6.7 
Whether the number of included patients change? 
Increase 22 73.3 
Reduce 4 13.3 
No change 1 3.3 
Unclear 3 10.0 
Change of inclusion criteria (Yes) (n=30) 12 40.0 
Changed factors of inclusion criteria (n=12) 
Population 4 33.3 
Intervention 6 50.0 
Comparison 7 58.3 
Outcome 9 75.0 
Whether to change the number of databases searched (n=30) 
Change 
  
Add 10 databases 1 3.3 
Add 3 to 4 databases 3 10.0 
Add 1 to 2 databases 3 10.0 
Reduce 1 database 4 13.3 
Reduce 2 databases 3 10.0 
No change 14 46.7 
Unclear 2 6.7 
Whether to search the years that original SRs retriev d (n=30) 
Yes 16 53.3 
No 12 40.0 
Unclear 2 6.7 
Whether to include RCTs included in the original SRs (Yes) (n=30) 25 83.3 
Proportion of previously RCTs of original SRs is included in the updated SRs (%) (n=25) 
0 to 30 1 4.0 
31 to 50 0 0.0 
51 to 70 2 8.0 
71 to 90 3 12.0 
91 to 99 2 8.0 
100 17 68.0 
SRs, systematic reviews; RCTs, randomized controlled trials. 
 
3.5. Methodological quality of RCTs included in original SRs and RCTs newly 
included in updated SRs 
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Twenty-one (70.0%) original SRs and 23 (76.7%) update  SRs assessed the 
methodological quality of included RCTs, although most SRs did not provide results 
of individual items. Eight updated SRs and nine original SRs reported the result of 
random sequence generation for 179 RCTs. There was a significant difference 
between previously included RCTs and newly included RCTs on high-risk results (P < 
0.001), but no significant differences were found between them on unclear risk (P = 
0.529) and low-risk results (P = 0.163). The previously included RCTs and newly 
included RCTs had the similar methodological quality in items of allocation 
concealment (P > 0.05). Considering the blinding of participants and personnel, 
relatively more newly included RCTs were rated as low risk (45.6%), compared with 
those previously included (25.5%). Compared to updated SRs, original SRs included 
less high-risk quality RCTs in terms of blinding of outcome assessment (P = 0.002) 
(Table 5). 
 
Table 5. Comparisons of methodological quality of previously included RCTs in original SRs and newly included 
RCTs in updated SRs 
Category Frequency Proportion (%) P value 
Random sequence generation (Reported in 8 updated SRs and 9 original SRs) 
High risk <0.001 
Previously included RCTs (n=126) 1 0.8 
Newly included RCTs (n=53) 9 17.0 
Unclear risk 0.529 
Previously included RCTs (n=126) 73 57.9 
Newly included RCTs (n=53) 28 52.8 
Low risk 0.163 
Previously included RCTs (n=126) 52 41.3 
Newly included RCTs (n=53) 16 30.2 
Allocation concealment (Reported in 8 updated SRs and 6 original SRs) 
High risk 0.252 
Previously included RCTs (n=113) 10 8.8 
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Newly included RCTs (n=70) 10 14.3 
Unclear risk >0.078 
Previously included RCTs (n=113) 79 69.9 
Newly included RCTs (n=70) 40 57.1 
Low risk >0.259 
Previously included RCTs (n=113) 24 21.2 
Newly included RCTs (n=70) 20 28.6 
Blinding of participants and personnel (Reported in 10 updated SRs and 10 original SRs) 
High risk >0.238 
Previously included RCTs (n=141) 48 34.0 
Newly included RCTs (n=90) 24 26.7 
Unclear risk <0.001 
Previously included RCTs (n=141) 57 40.4 
Newly included RCTs (n=90) 15 16.7 
Low risk <0.002 
Previously included RCTs (n=141) 36 25.5 
Newly included RCTs (n=90) 41 45.6 
Blinding of outcome assessment (Reported in 4 updated SRs and 3 original SRs) 
High risk <0.002 
Previously included RCTs (n=31) 0 0 
Newly included RCTs (n=25) 7 28.0 
Unclear risk >0.113 
Previously included RCTs (n=31) 19 61.3 
Newly included RCTs (n=25) 10 40.0 
Low risk >0.602 
Previously included RCTs (n=31) 12 38.7 
Newly included RCTs (n=25) 8 32.0 
SRs, systematic reviews; RCTs, randomized controlled trials. 
 
3.6. Results of comparable outcomes and change of precision 
 
We identified 130 comparable outcomes from 16 among the 30 pairs of included 
SRs, of which 97 (74.6%) were outcomes of the binary data and 33 (25.4%) were 
outcomes of the continuous data. As for the 130 comparable outcomes, four (3.1%) 
changed measures of effect size from the odds ratioto risk ratio, and the remaining 
126 (96.9%) used the same measures of effect size. Estimates of the updated SRs 
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were consistent with the original SRs for 127 (97.7%) comparable outcomes, and only 
three (2.3%) outcomes were observed with a significant hange (P < 0.05) in three SR 
updates (Table 6, Appendix Figures 3-6, Appendix Table 2). However, there were no 
new data from RCTs for 36 (27.7%) outcomes during the update process. Of the 94 
comparative outcomes that included new evidence, the width of the 95% confidence 
interval for 83 (88.3%) outcomes was narrowed. The standard error of 19 (20.2%) 
comparable outcomes were reduced between 0.1000 and 1.2000, 32 (34.0%) were 
reduced between 0.0499 and 0.0100, and 5 (5.3%) were inc eased between 0.0001 
and 0.0600 (Table 6, Appendix Table 3). We further compared results of newly 
included and previously included RCTs in the update SRs, for 47 comparative 
outcomes. Six outcomes were found with a statistical difference between the evidence 
of new RCTs and previously included RCTs of original SRs(Table 6, Appendix 
Figures 7-10). 
 
Table 6 Summaries of comparable outcomes 
Category Frequency Proportion (%) 
Number of SR pairs with comparable outcomes (n=30 Pairs) 16 100.0 
Number of comparable outcomes 130 100.0 
Category of comparable outcomes (n=130) 
 
Binary data 97 74.6 
Continuous data 33 25.4 
Measures of the comparable outcomes (n=130) 
  
HR 18 13.8 
OR 3 2.3 
RR 72 55.4 
OR and RR 4 3.1 
SMD 12 9.2 
MD 21 16.2 
Whether the measures of effect size change (n=130) 
 
Change OR to RR 4 3.1 
No change 126 96.9 
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Whether the comparable outcomes change (n=130)  
 
Change 3 2.3 
Binary data 2 1.5 
Continuous data 1 0.8 
No change 127 97.7 
Binary data 95 73.1 
Continuous data 32 24.6 
Whether the comparable outcomes added new RCTs in theupdated SRs (n=130) 
 
Yes 94 72.3 
No 36 27.7 
Whether the precision of the comparable outcomes change between updated SRs and original SRs (n=94) 
Improve 83 88.3 
Binary data 58 61.7 
Continuous data 25 26.6 
Reduce 5 5.3 
Binary data 3 3.2 
Continuous data 2 2.1 
No change 6 6.4 
Binary data 3 3.2 
Continuous data 3 3.2 
Change of standard error of comparable outcomes (n=94) 
  
-1.2000 to -0.1000 19 20.2 
-0.0999 to -0.0500 19 20.2 
-0.0499 to -0.0100 32 34.0 
-0.0099 to -0.0001 13 13.8 
0.0000 to 0.0600 11 11.7 
Is there a statistical difference between the evidence of newly RCTs and previously RCTs in the comparable outcomes (n=47) 
Yes 6 12.8 
No 41 87.2 
SRs, systematic reviews; RCTs, randomized controlled trials; HR, hazard ratio; OR, odds ratio; RR, risk ratio; 
SMD, standard mean difference; MD, mean difference. 
 
4. Discussion 
  
4.1. Summary of findings 
  
We conducted a comprehensive literature search and identified 30 pairs of 
updated and original SRs, which were published in 48 journals between 1994 and 
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2018. There were mainly four reasons for the authors to update their original SRs, and 
the most common reason was to incorporate new trials. Only ten pairs of updated and 
original SRs conducted subgroup analyses, no more than 25.0% pairs of SRs 
performed sensitivity analyses, and only two SRs conducted meta-regression analyses. 
It is well known that heterogeneity has a crucial impact on the interpretation of the 
results of SRs, while sensitivity analysis, subgroup analysis, and meta-regression 
analysis are the main methods for exploring heterogeneity. Therefore, future research 
should conduct these analyses to explore heterogeneity to make the results of the 
meta-analysis more credible. GRADE system is a toolhat can be used to rate the 
quality of evidence of SRs and other bodies of evidnce, and the Cochrane 
Collaboration recommended authors to use GRADE for all important outcomes in 
their SRs [25, 26]. The previous study has indicated that reviews with a high level of 
certainty in the results assessed by the GRADE tool were less likely to change by 
adding new evidence [10]. GRADE can help interpret changes in results between 
original and updated systematic reviews, as well as help decide whether to update SRs 
[10]. However, the current study found only 8.3% of the included SRs used the 
GRADE to assess the quality of evidence. Thus, the application of GRADE needs to 
be further promoted. 
All the included SRs reported inclusion criteria in terms of specified participants, 
interventions, comparisons, and outcomes. The inclusion criteria for most updated 
SRs remain unchanged, although more detailed inclusion criteria were applied in 
some. More than 70.0% SRs assessed the risk of bias of ncluded RCTs, but no more 
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than 35.0% SRs provided the detailed result of individual items. The updated SRs  
incorporated more RCTs with high-risk of bias regarding random sequence generation 
and blinding of outcome assessment, compared to original SRs. However, compared 
with RCTs previously included in original SRs, the n wly included RCTs more often 
clarified the blinding of participants and personnel. These, to some extent, indicated 
that the quality of previously included RCTs and newly included RCTs was generally 
similar. 
We identified 130 comparable outcomes from sixteen pairs of original and 
updated SRs. Among the 130 outcomes, only three wer found to have statistical 
differences between the updated and original SRs. The statistical difference was 
changed for one binary outcome after changing the measure of effect size from the 
odds ratio to risk ratio without new evidence added uring the update process. The 
other two outcomes incorporated new RCTs addition to RCTs previously included in 
the original SRs. The new evidence may contribute to the change in the overall effect 
size. There were no changes for 96.9% of the outcomes in the SR updates, including 
those (27.7%) that did not integrate new evidence during the update process. This 
result is consistent with findings from a previous study [22], in which Bashir et al. 
applied classification trees to model the risk of cnclusion changes in SR updates and 
found that 68.0% of the SRs did not exhibit a change in the conclusion in their 
updates. Therefore, we can conclude that the results of most updated SRs are 
generally consistent with results of the original SRs. 
Based on a comparison of standard errors of effect size estimates for 94 
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comparable outcomes, we observed that 88.3% of the outcomes showed an 
improvement in precision. Outcomes with fewer randomized controlled trials are 
expected to have wider confidence intervals [27]. Therefore, the incorporation of new 
trials in updated SRs will increase the sample sizeand improve the precision of the 
results. However, the precision was reduced in five outcomes after incorporating new 
evidence in updated SRs. Six outcomes did not exhibit a change in precision, but their 
effect size may have changed. Overall, the precision of effect size estimates could be 
improved for most comparable outcomes in updated SRs.  
 
4.2. Implications for future research 
 
A previous study, published in 2007 by Moher et al, summarized the methods 
and strategies describing when and how to update systematic reviews [19]. The 
current study found that the updated SRs could increase the precision of most 
outcomes, although almost all the results of updated SRs were consistent with the 
results of the original SRs.  
The average update time of SRs was 56.0 months, which may not be optimal. 
The Cochrane collaboration recommended that SRs should be updated based on need 
and priority [28]. It is difficult to know when a given review might become out of 
date, but tools have been available to help determine when a review needs to be 
updated [10, 28, 29]. Previous studies indicated that updating meta-analyses may 
result in biased treatment estimates and inflated type I error rates [30]. Therefore, we 
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should take the appropriate approach to update SRs at the appropriate time interval. 
Otherwise, it will not only waste resources and time but also produce inaccurate 
results and even mislead clinical practice. Future research should fully consider the 
need for updating, including treatment characteristics, statistical methods, clinical 
endpoints, availability of resources, and the impact of treatment on public health when 
updating SRs to ensure that the results of SRs better guide the clinical practice [19]. 
Recently, a novel approach to SR updating, living systematic reviews have been 
developed [31], by continually incorporating new evid nce as it becomes available. 
Although there are many challenges in statistical methods, production processes, peer 
and editorial review, and publication [31-33], living SRs may be particularly 
important in fields where research evidence is rapidly emerging, current evidence is 
uncertain, and new research may change policy or practice decisions [28, 32]. Future 
reviewers can reasonably adopt living SRs to reduce the time of translating results of 
new research into health practice and reduce the waste of research investment by 
society [32]. 
Our study also revealed that the overall quality of RCTs was low, and most SRs 
did not provide the result of individual items of quality assessment. Therefore, further 
research should clearly provide the results of quality assessment and incorporate 
high-quality RCTs to provide more reliable evidence. Majority of the included SRs 
did not conduct subgroup analyses, sensitivity analysis, and meta-regression analysis, 
so the exploration of heterogeneity still needs to be improved. Most updated SRs only 
briefly described reasons for updating and some SRs cannot be identified as updated 
24 
SRs which should be considered in the peer-reviewing a d editorial process. 
Researchers, journal editors, and peer reviewers should fully assess the need for 
updates and encourage authors to clarify the detailed reasons for the updates. 
 
4.3. Strengths and limitations 
 
To be the best of our knowledge, this is the first study to investigate the general 
characteristics, statistical analyses, and methodological quality of included RCTs of 
updated SRs and original SRs, and to compare the precision of outcomes between 
updated and original SRs. We also assessed changes in outcomes after including new 
evidence in updated SRs. There are also some limitations in our study. First, only SRs 
of RCTs published in English were enrolled, so that findings may not apply to SRs 
published in other languages and SRs of other types such as cohort studies and 
observational studies [5]. Second, although this study included 60 SRs in total, the 
number of comparable SRs and comparable outcomes was rather small, and the 
available evidence was not sufficient for conducting stratified analyses. Third, 
outcome changes and differences in precision may be affected by different systematic 
review methods, although we have compared the population, intervention, comparison, 
outcomes and statistical methods between updated SRs and original SRs to make the 
outcomes comparable, and performed analyses using the comparable outcomes. 
Fourth, analyses associated with effect estimates of comparable outcomes were 
restricted as some outcomes did not integrate original and new evidence during the 
25 
update process. Finally, we did not include Cochrane systematic reviews because of 
time and resource restrictions in the current study, and we plan to conduct a study to 
compare the characteristics and outcomes of Cochrane reviews between the updated 
SRs and original SRs. 
 
5. Conclusions 
 
Updating SRs could increase the precision of estimates of treatment effects for 
most comparable outcomes, although the results of almost all updated SRs were 
similar to the original SRs. Future research is requir d to fully consider multiple 
factors when updating SR to ensure that the results of SRs better guide the clinical 
practice and avoid wasting resources and time. 
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Figure legends 
Figure 1. Published years of the included SRs. 
Figure 2. Categories of disease of included SRs (according to ICD-11). Not 
applicable indicates that the topic of included SRs does not focus on diseases, such as 
the use of frozen plasma and the promotion of exclusive breastfeeding. 
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variables of the mean difference. 


What is new? 
 
Key findings 
 Systematic reviews did not exhibit outcome changes during the update process. 
 Updating systematic reviews could increase the precision of estimates of 
treatment effects. 
 Most updated systematic reviews only briefly describe the reasons for updating 
and some cannot be identified as updated SRs. 
What this adds to what was known? 
 This study compared the general characteristics, statistical methods, and the 
precision of outcomes between updated SRs and original SRs. 
What is the implication and what should change now? 
 Researchers, journal editors, and peer reviewers should fully assess the need for 
updates and encourage authors to clarify the detailed reasons for the updates.  
 Future research should fully consider multiple factors when updating systematic 
reviews to ensure that the results of systematic reviews better guide the clinical 
practice and avoid wasting resources and time. 
